215 related articles for article (PubMed ID: 2560431)
21. Biochemical and behavioral studies on the interaction between mu- and kappa-opiate agonists in mice.
Thorat SN; Veeranna ; Reddy PL; Bhargava HN
Brain Res; 1993 Jul; 615(2):191-8. PubMed ID: 8395957
[TBL] [Abstract][Full Text] [Related]
22. Opioid antagonists and drinking: evidence of kappa-receptor involvement.
Leander JD; Hynes MD
Eur J Pharmacol; 1983 Mar; 87(4):481-4. PubMed ID: 6303802
[TBL] [Abstract][Full Text] [Related]
23. Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action.
Millan MJ; Członkowski A; Lipkowski A; Herz A
J Pharmacol Exp Ther; 1989 Oct; 251(1):342-50. PubMed ID: 2571723
[TBL] [Abstract][Full Text] [Related]
24. Effects of the benzomorphan kappa-opiate, MR 2266 and its (+) enantiomer MR 2267, on thermonociceptive reactions in different strains of mice.
Bansinath M; Ramabadran K; Turndorf H; Puig MM
Neurosci Lett; 1990 Sep; 117(1-2):212-7. PubMed ID: 1963214
[TBL] [Abstract][Full Text] [Related]
25. Mu antagonist and kappa agonist properties of beta-funaltrexamine (beta-FNA) in vivo: long-lasting spinal analgesia in mice.
Qi JA; Heyman JS; Sheldon RJ; Koslo RJ; Porreca F
J Pharmacol Exp Ther; 1990 Mar; 252(3):1006-11. PubMed ID: 2156986
[TBL] [Abstract][Full Text] [Related]
26. Kappa opioids in rhesus monkeys. III. Dependence associated with chronic administration.
Gmerek DE; Dykstra LA; Woods JH
J Pharmacol Exp Ther; 1987 Aug; 242(2):428-36. PubMed ID: 3302208
[TBL] [Abstract][Full Text] [Related]
27. Antagonism of the acute pharmacological actions of morphine by panax ginseng extract.
Ramarao P; Bhargava HN
Gen Pharmacol; 1990; 21(6):877-80. PubMed ID: 2279687
[TBL] [Abstract][Full Text] [Related]
28. Analgesia produced by low doses of the opiate antagonist naloxone in arthritic rats is reduced in morphine-tolerant animals.
Kayser V; Besson JM; Guilbaud G
Brain Res; 1986 Apr; 371(1):37-41. PubMed ID: 3011202
[TBL] [Abstract][Full Text] [Related]
29. Augmentation of spinal morphine analgesia and inhibition of tolerance by low doses of mu- and delta-opioid receptor antagonists.
Abul-Husn NS; Sutak M; Milne B; Jhamandas K
Br J Pharmacol; 2007 Jul; 151(6):877-87. PubMed ID: 17502848
[TBL] [Abstract][Full Text] [Related]
30. Intrathecally administered dynorphin-(1-17) modulates morphine-induced antinociception differently in morphine-naive and morphine-tolerant rats.
Schmauss C; Herz A
Eur J Pharmacol; 1987 Mar; 135(3):429-31. PubMed ID: 2884124
[TBL] [Abstract][Full Text] [Related]
31. Chronic administration of morphine and naltrexone up-regulate mu-opioid binding sites labeled by [3H][D-Ala2,MePhe4,Gly-ol5]enkephalin: further evidence for two mu-binding sites.
Rothman RB; Bykov V; Long JB; Brady LS; Jacobson AE; Rice KC; Holaday JW
Eur J Pharmacol; 1989 Jan; 160(1):71-82. PubMed ID: 2540993
[TBL] [Abstract][Full Text] [Related]
32. Unidirectional analgesic cross-tolerance between morphine and levorphanol in the rat.
Moulin DE; Ling GSF; Pasternak GW
Pain; 1988 May; 33(2):233-239. PubMed ID: 2837716
[TBL] [Abstract][Full Text] [Related]
33. Characterization of the effects of the acute and chronic administration of phencyclidine on body temperature in the rat: lack of evidence for the involvement of opiate receptors.
Pechnick RN; George R
J Pharmacol Exp Ther; 1989 Mar; 248(3):900-6. PubMed ID: 2539463
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological characterization of buprenorphine, a mixed agonist-antagonist with kappa 3 analgesia.
Pick CG; Peter Y; Schreiber S; Weizman R
Brain Res; 1997 Jan; 744(1):41-6. PubMed ID: 9030411
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological characterization of nalorphine, a kappa 3 analgesic.
Paul D; Pick CG; Tive LA; Pasternak GW
J Pharmacol Exp Ther; 1991 Apr; 257(1):1-7. PubMed ID: 1850462
[TBL] [Abstract][Full Text] [Related]
36. Evidence for the involvement of central opioidergic systems in L-tyrosine methyl ester-induced analgesia in the rat.
Ramarao P; Bhargava HN
Pharmacology; 1988; 37(1):1-7. PubMed ID: 3420162
[TBL] [Abstract][Full Text] [Related]
37. Different opioid systems may participate in post-electro-convulsive shock (ECS) analgesia and catalepsy.
Urca G; Yitzhaky J; Frenk H
Brain Res; 1981 Aug; 219(2):385-96. PubMed ID: 6266608
[TBL] [Abstract][Full Text] [Related]
38. Di-isopropyl phosphofluoridate-induced antinociception: possible role of endogenous opioids.
Koehn GL; Henderson G; Karczmar AG
Eur J Pharmacol; 1980 Jan; 61(2):167-73. PubMed ID: 6243566
[TBL] [Abstract][Full Text] [Related]
39. Antinociception in the rat induced by a cold environment.
Osgood PF; Carr DB; Kazianis A; Kemp JW; Atchison NE; Szyfelbein SK
Brain Res; 1990 Jan; 507(1):11-6. PubMed ID: 2154295
[TBL] [Abstract][Full Text] [Related]
40. Endothelin receptor antagonists restore morphine analgesia in morphine tolerant rats.
Bhalla S; Matwyshyn G; Gulati A
Peptides; 2003 Apr; 24(4):553-61. PubMed ID: 12860199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
